Literature DB >> 19337160

Role of iron in osteoporosis.

Eugene D Weinberg1.   

Abstract

Osteoporosis is a remarkably frequent complication of iron loading conditions such as thalassemia, sicklemia, African siderosis, hemochromatosis, smoking, alcoholism, HIV infection, and cessation of menstruation. The metal suppresses osteoblast formation of bone and may also stimulate osteoclast resorption of bone. Iron also inhibits anterior pituitary synthesis of gonadotrophs. This, in turn, results in depressed formation of gonadal hormones. The tendency of iron-loaded persons to become osteoporotic may be enhanced by gonadal hormone deficiency. Iron binding agents that could specifically withhold excess skeletal iron (and be excreted as the iron chelate) might have therapeutic utility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19337160

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  20 in total

1.  Downregulation of ferroportin 1 expression in hFOB1.19 osteoblasts by hepcidin.

Authors:  Youjia Xu; Wei Zhang; Peng Zhang; Li Xiao; Aidong Wang; Pierre Sirois; Kai Li
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.

Authors:  Bin Chen; Guang-Fei Li; Ying Shen; X I Huang; You-Jia Xu
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

3.  Laser-induced plasma spectroscopy (LIPS): use of a geological tool in assessing bone mineral content.

Authors:  László Andrássy; Izabella Gomez; Ágnes Horváth; Katalin Gulyás; Zsófia Pethö; Balázs Juhász; Harjit Pal Bhattoa; Zoltan Szekanecz
Journal:  Lasers Med Sci       Date:  2018-02-17       Impact factor: 3.161

4.  Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.

Authors:  Edwin Patino; Stephen B Doty; Divya Bhatia; Kelly Meza; Yuan-Shan Zhu; Stefano Rivella; Mary E Choi; Oleh Akchurin
Journal:  Kidney Int       Date:  2020-06-20       Impact factor: 10.612

5.  Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Authors:  Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi
Journal:  Blood       Date:  2010-06-16       Impact factor: 22.113

6.  Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology.

Authors:  Bo-Cheng Liang; Xiao-Lin Shi; Chun-Wen Li; Zhen-Yu Shi; Wei-Tao He; Jian-Liang Yao; Ling-Cheng Kong; Xu-Yun Li
Journal:  Chin J Integr Med       Date:  2016-07-07       Impact factor: 1.978

7.  Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration.

Authors:  Guo-yang Zhao; Dong-hua Di; Bo Wang; Xi Huang; You-jia Xu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

8.  Iron and menopause: does increased iron affect the health of postmenopausal women?

Authors:  Jinlong Jian; Edward Pelle; Xi Huang
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

Review 9.  Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis.

Authors:  Laura Toxqui; M Pilar Vaquero
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

Review 10.  Molecular Aspects of Bone Resorption in β-Thalassemia Major.

Authors:  Najmaldin Saki; Saeid Abroun; Fatemeh Salari; Fakher Rahim; Mohammad Shahjahani; Mohammadi-Asl Javad
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.